Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Capital Expenditures: 2014-2024

Historic Capital Expenditures for AC Immune (ACIU) over the last 11 years, with Dec 2024 value amounting to $657,517.

  • AC Immune's Capital Expenditures fell 408.20% to -$991,309 in Q3 2025 from the same period last year, while for Sep 2025 it was -$632,191, marking a year-over-year decrease of 159.45%. This contributed to the annual value of $657,517 for FY2024, which is 27.19% down from last year.
  • AC Immune's Capital Expenditures amounted to $657,517 in FY2024, which was down 27.19% from $903,011 recorded in FY2023.
  • Over the past 5 years, AC Immune's Capital Expenditures peaked at $2.9 million during FY2021, and registered a low of $657,517 during FY2024.
  • Moreover, its 3-year median value for Capital Expenditures was $903,011 (2023), whereas its average is $948,879.
  • As far as peak fluctuations go, AC Immune's Capital Expenditures surged by 52.81% in 2021, and later tumbled by 55.40% in 2022.
  • Yearly analysis of 5 years shows AC Immune's Capital Expenditures stood at $1.9 million in 2020, then skyrocketed by 52.81% to $2.9 million in 2021, then slumped by 55.40% to $1.3 million in 2022, then fell by 29.79% to $903,011 in 2023, then fell by 27.19% to $657,517 in 2024.